Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
10/2005
10/06/2005WO2005092841A1 Compounds having beta-agonist activity
10/06/2005WO2005092836A1 Opioid receptor antagonists
10/06/2005WO2005092011A2 Mitotic kinesin inhibitors
10/06/2005WO2005091752A2 Acrylonitrile derivatives for inflammation and immune-related uses
10/06/2005WO2005066135A3 Pyrrole and pyrazole daao inhibitors
10/06/2005WO2005009344A3 Acylated amino acid amidyl pyrazoles and related compounds
10/06/2005US20050222424 Phenyloxyalkanonic acid derivatives as hppar activators
10/06/2005US20050222419 Process for preparing pesticidal intermediates
10/06/2005US20050222240 COX-2 inhibitory activity; useful for the treatment of arthritis and other conditions due to inflammation; 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide
10/06/2005US20050222239 Pyrazole-amine compounds for the treatment of neurodegenerative disorders
10/06/2005US20050222238 Deuterated substituted pyrazolylbenzylsulfonamides and medicaments comprising said compounds
10/06/2005US20050222237 Inhibitors of glycogen synthase kinase-3 (GSK-3), a serine/threonine protein kinase; for treatment and prevention of diabetes and Alzheimer's disease
10/06/2005US20050222230 3,4-diarylpyrazoles and their use in the therapy of cancer
10/06/2005US20050222215 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
10/06/2005US20050222200 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/06/2005US20050222146 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
10/06/2005US20050221990 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
10/06/2005US20050221989 O-cyclopropyl-carboxanilides and their use as fungicides
10/06/2005US20050221988 For selectively controlling broadleaf and gramineous weeds in crops of useful plants
10/06/2005US20050217535 Triazo dye containing pyrrazolone group; dyeing paper, textile, overhead slides
10/06/2005CA2560895A1 Acrylonitrile derivatives for inflammation and immune-related uses
10/06/2005CA2560368A1 Compounds for the treatment of diseases
10/06/2005CA2560213A1 Mitotic kinesin inhibitors
10/06/2005CA2559733A1 Inhibitors of histone deacetylase
10/06/2005CA2559035A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/06/2005CA2557794A1 Opioid receptor antagonists
10/05/2005EP1582517A1 Blood-brain barrier disruption inhibitors
10/05/2005EP1582211A1 Jnk inhibitor
10/05/2005EP1581516A2 3-heterocyclic benzylamide derivatives as potassium channel openers
10/05/2005EP1581503A2 Ophthalmic compositions for treating ocular hypertension
10/05/2005EP1581502A1 Process for the preparation of an essentially pure polymorph of an n-pyrazolyl-n'-naphthyl-urea
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581470A1 2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties
10/05/2005EP1259476B1 Chlorination of an aniline in ortho in a hydrofluoric medium
10/05/2005EP1202733B1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
10/05/2005CN1678614A Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
10/05/2005CN1678589A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them
10/05/2005CN1678588A Pyrazole derivatives and process for the production thereof
10/05/2005CN1678587A CCK-1 receptor modulators
10/05/2005CN1678573A Diarylurea derivatives and their use as chloride channel blockers
10/05/2005CN1678372A Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/05/2005CN1678192A Arthropodicidal anthranilamides
10/05/2005CN1221544C Pyrazole cyclic AMP-specific PDE inhibitors
10/05/2005CN1221533C 7-amino-1H-indole derivatives
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/05/2005CN1221524C Diphenyl ether compounds useful in therapy
10/05/2005CN1221257C Utilization of aryl (or heteroaryl) azolylcarbinol derivatives in prepn. of medicament for treatment of neurogenic inflammation
10/04/2005US6951949 such as 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide for treatment of arthritis
10/04/2005US6951878 Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases)
09/2005
09/29/2005WO2005090483A1 Azo compound
09/29/2005WO2005090340A1 Piperidine-1-carboxamide derivative
09/29/2005WO2005090322A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005090314A1 1-phenyl and 1-pyridylpyrazole derivatives and their use as pesticides
09/29/2005WO2005090313A1 N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides
09/29/2005WO2005090312A1 5-aminoalkylpyrazole derivatives as pesticidal agents
09/29/2005WO2005090298A1 Sulphonamide derivatives
09/29/2005WO2005090297A1 Sulphonamide derivatives
09/29/2005WO2005090296A2 N-substituted benzene sulfonamides
09/29/2005WO2005090292A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005089511A2 Novel pharmaceutical forms, and methods of making and using the same
09/29/2005WO2005051917A9 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
09/29/2005US20050215798 Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles
09/29/2005US20050215797 Pyrazole derivatives and process for the production thereof
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215612 Anticancer agents; such as succinic acid mono-[5-(1-benzyl-1H-indazol-3-yl)-furan-2-ylmethyl]ester, sodium salt; inhibit cancer cell growth
09/29/2005US20050215595 Indazole derivatives and methods for using the same
09/29/2005US20050215587 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions
09/29/2005CA2559919A1 Sulphonamide derivatives
09/29/2005CA2559047A1 N-substituted benzene sulfonamides
09/29/2005CA2554855A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005CA2554609A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/28/2005EP1580189A1 4-amino-5-methylpyrazole derivatives and process for production thereof
09/28/2005EP1578737A1 Substituted heterocyclic compounds
09/28/2005EP1578735A1 Cyclopentyl glutaramides and their use as neutral endopeptidase inhibitors
09/28/2005EP1578729A1 1-alkyl-3-aminoindazoles
09/28/2005EP1578715A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
09/28/2005CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals
09/28/2005CN1673219A Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
09/28/2005CN1220683C Acyl derivatives for treating VLA-4 related disorders
09/27/2005US6949654 Treating diseases arising from reactive oxygen species and/or excess Zn ions, in particular stroke, Parkinson's disease and Alzheimer's disease.
09/27/2005US6949580 Anticancer agents; restenosis; antiinflammatory agents; cardiovascular disorders
09/27/2005US6949579 Central nervous system disorders; antidiabetic agents
09/27/2005US6949578 useful in selectively inhibiting or antagonizing the alpha v beta 3 and/or alpha v beta 5 integrins; treatment of osteoporosis, humoral hypercalcemia of malignancy, Paget's disease, tumor metastasis, solid tumor growth (neoplasia), angiogenesis
09/27/2005US6949568 Such as N-(2-(4-(3-phenyl-4-methoxyphenyl)aminophenyl)ethyl)-2-hydroxy-2-(3 -hydroxymethyl-4-hydroxyphenyl)ethylamine; for treatment of chronic obstructive pulmonary disease
09/27/2005US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
09/27/2005US6949551 Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides
09/22/2005WO2005087710A1 Aminophenylpropanoic acid derivative
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005US20050209459 Processes for the preparation of 1,5-diryl-3-substituted-pyrazoles
09/22/2005US20050209297 Pyrazole derivatives
09/22/2005US20050209197 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
09/22/2005US20050208582 Pyrazole compounds and pharmaceutical compositions comprising the compound
09/22/2005CA2560111A1 Aminophenylpropanoic acid derivative
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/21/2005EP1575922A1 Biphenyl derivatives and their use as fungicides
09/21/2005EP1575495A2 Compounds and methods
09/21/2005EP1575486A2 Method and compositions for identifying anti-hiv therapeutic compounds
09/21/2005CN1671669A Synthesis of diaryl pyrazoles
09/21/2005CN1671379A Hydrazonopyrazole derivatives and their use as therapeutics
09/21/2005CN1219772C 1, 3-aryl group substituted pyrazoline whose 5 position contains ester group and its liquid phase synthesis method